Testing effectiveness (Phase 2)Looking for participantsNCT04641247
What this trial is testing
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Who this might be right for
Ovarian NeoplasmsBreast Neoplasms
GlaxoSmithKline 37